PS Ratio: 2.12

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 2.12 is 21% below its estimated 1-year average of 2.70, near the low end of its estimated 1-year range (1.86–3.33).

As of 2026-10-06T20:35:21.597Z.

AIDX PS Ratio Metrics

P/S vs. estimated history

At 2.12, P/S is below its estimated 1-year median — higher than 6% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for 20/20 Biolabs Inc. (AIDX)?

The P/S ratio for AIDX stock is 2.12.

Is 20/20 Biolabs Inc.'s P/S ratio high or low?

The P/S ratio of 2.12 is 21% below its estimated 1-year average of 2.70, near the low end of its estimated 1-year range (1.86–3.33).

Related Metrics